Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$1.24 | $0 | |||
08/13/2024 | Q2 2024 | -$0.97 | $0 | |||
05/14/2024 | Q1 2024 | -$1.03 | $0 | |||
03/05/2024 | Q4 2023 | -$1.50 | $2.05 M | |||
11/09/2023 | Q3 2023 | -$1.60 | $0 | |||
08/11/2023 | Q2 2023 | -$1.47 | $0 | |||
05/12/2023 | Q1 2023 | -$1.80 | $0 | |||
03/08/2023 | Q4 2022 | -$3.46 | $0 | |||
11/10/2022 | Q3 2022 | -$0.29 | $0 | |||
08/12/2022 | Q2 2022 | -$0.24 | $0 | |||
05/12/2022 | Q1 2022 | $0.23 | $0 | |||
03/18/2022 | Q4 2021 | -$1.82 | $0 | |||
11/12/2021 | Q3 2021 | -$0.69 | $0 | |||
08/16/2021 | Q2 2021 | -$0.22 | $0 | |||
07/22/2021 | Q1 2021 | -$0.26 | $0 | |||
03/30/2021 | Q4 2020 | -$0.26 | $0 | |||
11/10/2020 | Q3 2020 | -$0.29 | $0 | |||
08/13/2020 | Q2 2020 | -$16.08 | $0 | |||
05/13/2020 | Q1 2020 | $0.00 | $0 |
Jasper Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
The conference call for Jasper Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Jasper Therapeutics, Inc.'s latest earnings report can be read online.
Jasper Therapeutics, Inc. (:JSPRW) has a recorded net income of $0. Jasper Therapeutics, Inc. has generated $-6.18 earnings per share over the last four quarters.
Jasper Therapeutics, Inc. (:JSPRW) has a price-to-earnings ratio of -1.39 and price/earnings-to-growth ratio is -0.2.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED